Revista

Nome:
Health Economics web
Rankings:
Pontos Posição
CEF.UP+NIPE (average of all rankings) (2012) 31.45 115/501
ABS (2010) 50.0 159/288
Australian RC (2010) 75.0 180/479
Axarloglou and Theoharakis (2003) 2.46 68/94
Carlos III (2010) 20.0 55/153
CNRS (2008) 80.0 26/336
Combes and Linnemer (2003) 17.0 185/253
Ideas discounted recursive impact factor (2012) 2.89 148/396
ISI, JCR SSE, Article Influence Score (2010) 9.58 95/316
ISI, JCR SSE, Impact Factor (2010) 26.18 58/388
Kalaitzidakis et al (2010) 1.74 77/196
Kodrzycki and Yu (2006) 3.48 80/177
Lubrano et al (2003) 30.0 139/211
Qualis (2008) 75.0 80/200
Ritzberger (2008) 3.9 84/153
Schneider and Ursprung (2008) 40.0 134/278
Source Normalized Impact per Paper (SNIP) (2011) 16.68 120/476
Tinbergen Institute (2011) 25.0 53/119
Article Influence Score (2021) 1.36 139/409
Article Influence Score (2019) 1.31 112/428
Impact Factor (2021) 2.4 201/409
Impact Factor (2019) 2.25 132/440
Impact Factor (5 year) (2021) 3.23 157/409
Impact Factor (5 year) (2019) 2.67 136/428
SJR - Scimago (2021) 1.09 186/558
SJR - Scimago (2019) 1.57 125/549
Count (2021) 1.0 566/662
Artigos 27:

The Unintended Consequences of Hospital Strikes on Patient Outcomes Evidence from Multiple Strikes in the Portuguese National Health Service
Eduardo Costa
vol. 31, 2022, p. 2499-2511.

Air Pollution and Noncognitive Traits among Chinese Adolescents
Mengyao Li , Susana Ferreira, Travis A. Smith, Xin Zhang
vol. 30, 2021, p. 478-488.

Doctors' Response to Queues: Evidence from a Portuguese Emergency Department
Bruno Martins, Luís C.S. Filipe
vol. 29, 2020, p. 123-137.

Entry and Price Competition in the Over-the-Counter Drug Market after Deregulation: Evidence from Portugal
Ana Moura, Pedro Pita Barros
vol. 29, 2020, p. 865-877.

Causes of Regional Variation in Dutch Healthcare Expenditures: Evidence from Movers
Ana Moura, Martin Salm, Minke Remmerswaal
vol. 28, 2019, p. 1088-1098.

Does Global Drug Innovation Correspond to Burden of Disease? The Neglected Diseases in Developed and Developing Countries
Eliana Barrenho, Marisa Miraldo, Peter C. Smith
vol. 28, 2019, p. 123-143.

Missing Data in Trial-Based Cost-Effectiveness Analysis: An Incomplete Journey
Baptiste Leurent, Manuel Gomes, James R. Carpenter
vol. 27, 2018, p. 1024-1040.

Socio-economic status and physicians' treatment decisions.
Kurt Brekke, Tor Helge Holmas, Karin Monstad, Odd Rune Straume
vol. 27, 2018, p. e77-e89.

Do hospitals respond to rivals' quality and efficiency? A spatial panel econometric analysis.
Francesco Longo, Luigi Siciliani, Hugh Gravelle, Rita Santos
vol. 26, 2017, p. 38-62.

Pure, White and Deadly . . . Expensive: A Bitter Sweetness in Health Care Expenditure
Vitor Castro
vol. 26, 2017, p. 1644-1666.

Upcoding in a National Health Service: The Evidence from Portugal
Pedro Pita Barros, Gisele Braun
vol. 26, 2017, p. 600-618.

Addressing Missing Data in Patient-Reported Outcome Measures (PROMs): Implications for the Use of PROMs for Comparing Provider Performance
Manuel Gomes, Nils Gutacker, Chris Bojke, Andrew Street
vol. 25, 2016, p. 515-528.

The Impact of an Increase in User Costs on the Demand for Emergency Services: The Case of Portuguese Hospitals
Pedro Ramos, Alvaro Almeida
vol. 25, 2016, p. 1372-1388.

Does Experience Rating Improve Obstetric Practices? Evidence from Italy
Sofia Amaral-Garcia, Paola Bertoli, Veronica Grembi
vol. 24, 2015, p. 1050-1064.

Inequity in the Face of Death
Pilar Garcia-Gomez, Erik Schokkaert, Tom Van Ourti, Teresa Bago de Uva
vol. 24, 2015, p. 1348-1367.

Disclosing Total Waiting Times for Joint Replacement: Evidence from the English NHS Using Linked HES Data
Elsa Marques, Sian Noble, Ashley W.Blom, William Hollingworth
vol. 23, 2014, p. 806-820.

General Budget Support: Has It Benefited the Health Sector?
Adélio Fernandes Antunes
vol. 22, 2013, p. 1440-1451.

Patient Classification Systems and Hospital Costs of Care for Knee Replacement in 10 European Countries
Francesc Cots, Pietro Chiarello, Xavier Salvador, Xavier Casteels
vol. 21, 2012, p. 116-128.

The Simple Economics of Risk-Sharing Agreements between the NHS and the Pharmaceutical Industry
Pedro Pita Barros
vol. 20, 2011, p. 461-470.

Double Health Insurance Coverage and Health Care Utilisation: Evidence from Quantile Regression
Sara Moreira, Pedro Pita Barros
vol. 19, 2010, p. 1075-1092.

Modelling Opportunity in Health under Partial Observability of Circumstances
Pedro Rosa Dias
vol. 19, 2010, p. 252-264.

Inequality of Opportunity in Health: Evidence from a UK Cohort Study
Pedro Rosa Dias
vol. 18, 2009, p. 1057-1074.

Giving Greater Financial Independence to Hospitals--Does It Make a Difference? The Case of English NHS Trusts
Giorgia Marini, Marisa Miraldo, Rowena Jacobs, Maria Goddard
vol. 17, 2008, p. 751-775.

Measuring the Effects of Work Loss on Productivity with Team Production
Sean Nicholson, Mark Pauly, Daniel Polsky, Claire Sharda, Helena Szrek, Marc Berger
vol. 15, 2006, p. 111-123.

Health Care Reform in Portugal: An Evaluation of the NHS Experience
Monica Duarte Oliveira, Carlos Gouveia Pinto
vol. 14, 2005, p. 203-220.

Utilization of Public Health Centres in Portugal: Effect of Time Costs and Other Determinants: Finite Mixture Models Applied to Truncated Samples
Óscar Lourenço, Pedro Augusto Ferreira
vol. 14, 2005, p. 939-953.

The Black Box of Health Care Expenditure Growth Determinants
Pedro Pita Barros
vol. 7, 1998, p. 533-544.

Voltar